| Symbol | COO |
|---|---|
| Name | COOPER COMPANIES, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Ophthalmic Goods |
| Address | 6101 BOLLINGER CANYON ROAD, SAN RAMON, CA 94583 |
| Telephone | 9254603600 |
| Fax | — |
| — | |
| Website | https://www.coopercos.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000711404 |
| Description | Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the second- largest player in the oligopolistic contact lens market. Over 50% of CooperVisions sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017. Additional info from NASDAQ: |
New Form SCHEDULE 13G - COOPER COMPANIES, INC. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0002100119-26-000305 <b>Size:</b> 7 KB
Read moreRosebrough Walter M Jr 🟡 adjusted position in 832 shares (2 derivative) of COOPER COMPANIES, INC. (COO) Transaction Date: Jan 03, 2026 | Filing ID: 000006
Read moreWEISS ROBERT S 🟡 adjusted position in 3.8K shares (2 derivative) of COOPER COMPANIES, INC. (COO) Transaction Date: Apr 01, 2026 | Filing ID: 000001
Read moreRivas Maria 🟡 adjusted position in 3.8K shares (2 derivative) of COOPER COMPANIES, INC. (COO) Transaction Date: Apr 01, 2026 | Filing ID: 000001
Read moreJay Colleen 🟡 adjusted position in 4.2K shares (2 derivative) of COOPER COMPANIES, INC. (COO) Transaction Date: Apr 01, 2026 | Filing ID: 000002
Read moreCarbone Barbara 🟡 adjusted position in 3.8K shares (2 derivative) of COOPER COMPANIES, INC. (COO) Transaction Date: Apr 01, 2026 | Filing ID: 000007
Read more